Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$23.89
-0.56%
Mkt Cap $1.58B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
Implied Upside
+92.5%
Consensus $46.00 vs current $23.89
NASDAQ·Healthcare·Biotechnology
$23.89
-0.56%
Mkt Cap $1.58B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
+92.5%
Consensus $46.00 vs current $23.89